Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,propertyPlantEquipment,totalCurrentAssets,shortTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,deferredLongTermLiab,otherCurrentAssets,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,changeToNetincome,capitalExpenditures,repurchaseOfStock,otherCashflowsFromInvestingActivities,otherCashflowsFromFinancingActivities,WC,language,region,quoteType,triggerable,quoteSourceName,currency,market,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,shortName,exchange,marketState,twoHundredDayAverageChangePercent,exchangeDataDelayedBy,esgPopulated,tradeable,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,epsTrailingTwelveMonths,epsForward,priceHint,epsCurrentYear,priceEpsCurrentYear,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (May 27, 2021) 4","Short Ratio (May 27, 2021) 4","Short % of Float (May 27, 2021) 4","Short % of Shares Outstanding (May 27, 2021) 4","Shares Short (prior month Apr 29, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry,address2
t0,ITMR,82625000.0,16387100,2889000,,-5477000,,-5523000,10416000,8385000,-4920000,-4920000,,-327000,,,,46000,11977000,16897000,3592000,-557000,,-5523000,-5523000,3206000.0,207469000.0,19992000.0,85831000.0,4599000.0,105823000.0,1340000.0,-122978000.0,1532000.0,841000.0,51869000.0,17237000.0,135000.0,4799000.0,96977000.0,27000000.0,10962000.0,117000.0,7146000.0,4499000.0,,,3000000.0,95000.0,726000.0,-281000.0,46383000.0,-1929000.0,46664000.0,42199000.0,-112000.0,-4798000.0,758000.0,-133000.0,222000.0,1712000.0,-2274000.0,,,,79740000.0,en-US,US,EQUITY,True,Delayed Quote,USD,us_market,20.76,1630526402,-0.5799999,21.5,21.5,20.3798,23943,Itamar Medical Ltd. - American ,NCM,PRE,-0.049141966,0,False,False,-2.7179003,20.3798 - 21.5,21.34,0.0,20.78,12,11,finmb_2689294,NasdaqCM,Itamar Medical Ltd.,USD,35579,39100,4.3999996,0.2689486,16.36 - 26.83,-6.0699997,-0.22623928,16.36,26.83,-1.11,-0.47,2,-1.17,-17.743591,5.55,18.894056,1.8659439,0.09875825,21.832912,-1.0729122,340196192,-44.17021,3.7405405,15,America/New_York,EDT,-14400000,0.62,,,26.83,16.36,18.89,21.83,35.58k,39.1k,16.39M,,10.06M,1.59%,57.81%,307.03k,7.73,,1.87%,302.83k,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-32.41%,-29.86%,-9.60%,-21.04%,44.63M,3.09,43.00%,28.71M,-12.31M,-14.46M,-1.11,,78.87M,5.11,7.02M,8.18,5.63,5.55,-12.21M,-9.82M,Value,3079883,Healthcare,257,"Itamar Medical Ltd., a medical technology company, develops and commercializes non-invasive medical devices and solutions for the treatment of respiratory sleep disorders. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enable to conduct home sleep apnea tests for the treatment of sleep apnea, such as obstructive sleep apnea; EndoPAT device that diagnoses endothelial dysfunction; and Loop device, a wrist device for measuring and recording physiological parameters, such as SpO2, respiration rate, and heart rate. The company operates in the United States, Canada, Europe, Israel, Japan, rest of the Asia Pacific, and internationally. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was incorporated in 1997 and is headquartered in Caesarea, Israel.",Caesarea,972 4 617 7000,1609372800,Israel,http://www.itamar-medical.com,86400,9 Halamish Street,972 4 627 5598,Medical Devices,North Industrial Zone PO Box 3579
t-1,ITMR,42932000.0,16387100,1938000,,-2960000,,-2940000,9556000,8839000,-2681000,-2681000,,-327000,,,,-20000,12772000,15453000,3933000,-279000,,-2940000,-2940000,140000.0,161006000.0,21068000.0,43072000.0,1837000.0,64140000.0,1140000.0,-119074000.0,1542000.0,1856000.0,9670000.0,17992000.0,135000.0,4705000.0,57439000.0,30000000.0,9598000.0,154000.0,7164000.0,4418000.0,897000.0,370000.0,-14000000.0,786000.0,-14626000.0,48000.0,-156000.0,1411000.0,46664000.0,-15483000.0,61000.0,-762000.0,236000.0,-775000.0,-137000.0,420000.0,-626000.0,-204000.0,,,39447000.0,en-US,US,EQUITY,True,Delayed Quote,USD,us_market,20.76,1630526402,-0.5799999,21.5,21.5,20.3798,23943,Itamar Medical Ltd. - American ,NCM,PRE,-0.049141966,0,False,False,-2.7179003,20.3798 - 21.5,21.34,0.0,20.78,12,11,finmb_2689294,NasdaqCM,Itamar Medical Ltd.,USD,35579,39100,4.3999996,0.2689486,16.36 - 26.83,-6.0699997,-0.22623928,16.36,26.83,-1.11,-0.47,2,-1.17,-17.743591,5.55,18.894056,1.8659439,0.09875825,21.832912,-1.0729122,340196192,-44.17021,3.7405405,15,America/New_York,EDT,-14400000,0.62,,,26.83,16.36,18.89,21.83,35.58k,39.1k,16.39M,,10.06M,1.59%,57.81%,307.03k,7.73,,1.87%,302.83k,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-32.41%,-29.86%,-9.60%,-21.04%,44.63M,3.09,43.00%,28.71M,-12.31M,-14.46M,-1.11,,78.87M,5.11,7.02M,8.18,5.63,5.55,-12.21M,-9.82M,Value,3079883,Healthcare,257,"Itamar Medical Ltd., a medical technology company, develops and commercializes non-invasive medical devices and solutions for the treatment of respiratory sleep disorders. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enable to conduct home sleep apnea tests for the treatment of sleep apnea, such as obstructive sleep apnea; EndoPAT device that diagnoses endothelial dysfunction; and Loop device, a wrist device for measuring and recording physiological parameters, such as SpO2, respiration rate, and heart rate. The company operates in the United States, Canada, Europe, Israel, Japan, rest of the Asia Pacific, and internationally. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was incorporated in 1997 and is headquartered in Caesarea, Israel.",Caesarea,972 4 617 7000,1609372800,Israel,http://www.itamar-medical.com,86400,9 Halamish Street,972 4 627 5598,Medical Devices,North Industrial Zone PO Box 3579
t-2,ITMR,45181000.0,16387100,1385000,,-2664000,,-2759000,8657000,7528000,-2514000,-2514000,,-293000,,,,95000,10999000,13513000,3471000,-150000,,-2759000,-2759000,855000.0,161456000.0,18032000.0,46036000.0,3896000.0,64068000.0,1136000.0,-116556000.0,1478000.0,912000.0,25153000.0,15410000.0,,4365000.0,57936000.0,16000000.0,10307000.0,,6476000.0,3389000.0,,,-8500000.0,782000.0,-9395000.0,-220000.0,-207000.0,979000.0,13000.0,-12513000.0,-4000.0,-2907000.0,456000.0,-1958000.0,-867000.0,460000.0,-895000.0,-204000.0,,,42526000.0,en-US,US,EQUITY,True,Delayed Quote,USD,us_market,20.76,1630526402,-0.5799999,21.5,21.5,20.3798,23943,Itamar Medical Ltd. - American ,NCM,PRE,-0.049141966,0,False,False,-2.7179003,20.3798 - 21.5,21.34,0.0,20.78,12,11,finmb_2689294,NasdaqCM,Itamar Medical Ltd.,USD,35579,39100,4.3999996,0.2689486,16.36 - 26.83,-6.0699997,-0.22623928,16.36,26.83,-1.11,-0.47,2,-1.17,-17.743591,5.55,18.894056,1.8659439,0.09875825,21.832912,-1.0729122,340196192,-44.17021,3.7405405,15,America/New_York,EDT,-14400000,0.62,,,26.83,16.36,18.89,21.83,35.58k,39.1k,16.39M,,10.06M,1.59%,57.81%,307.03k,7.73,,1.87%,302.83k,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-32.41%,-29.86%,-9.60%,-21.04%,44.63M,3.09,43.00%,28.71M,-12.31M,-14.46M,-1.11,,78.87M,5.11,7.02M,8.18,5.63,5.55,-12.21M,-9.82M,Value,3079883,Healthcare,257,"Itamar Medical Ltd., a medical technology company, develops and commercializes non-invasive medical devices and solutions for the treatment of respiratory sleep disorders. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enable to conduct home sleep apnea tests for the treatment of sleep apnea, such as obstructive sleep apnea; EndoPAT device that diagnoses endothelial dysfunction; and Loop device, a wrist device for measuring and recording physiological parameters, such as SpO2, respiration rate, and heart rate. The company operates in the United States, Canada, Europe, Israel, Japan, rest of the Asia Pacific, and internationally. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was incorporated in 1997 and is headquartered in Caesarea, Israel.",Caesarea,972 4 617 7000,1609372800,Israel,http://www.itamar-medical.com,86400,9 Halamish Street,972 4 627 5598,Medical Devices,North Industrial Zone PO Box 3579
t-3,ITMR,47696000.0,16387100,1377000,,-3232000,,-3242000,7857000,6016000,-3224000,-3224000,,-160000,,,,10000,8885000,12109000,2869000,-8000,,-3242000,-3242000,687000.0,161407000.0,16541000.0,48383000.0,3582000.0,64924000.0,1133000.0,-114157000.0,1465000.0,782000.0,37666000.0,13823000.0,,3885000.0,59570000.0,7500000.0,9677000.0,,4727000.0,2646000.0,,,-7500000.0,151000.0,-8028000.0,-220000.0,-1015000.0,336000.0,81000.0,-12776000.0,10000.0,-3743000.0,479000.0,-1054000.0,-728000.0,315000.0,-478000.0,-204000.0,-50000.0,-876000.0,45747000.0,en-US,US,EQUITY,True,Delayed Quote,USD,us_market,20.76,1630526402,-0.5799999,21.5,21.5,20.3798,23943,Itamar Medical Ltd. - American ,NCM,PRE,-0.049141966,0,False,False,-2.7179003,20.3798 - 21.5,21.34,0.0,20.78,12,11,finmb_2689294,NasdaqCM,Itamar Medical Ltd.,USD,35579,39100,4.3999996,0.2689486,16.36 - 26.83,-6.0699997,-0.22623928,16.36,26.83,-1.11,-0.47,2,-1.17,-17.743591,5.55,18.894056,1.8659439,0.09875825,21.832912,-1.0729122,340196192,-44.17021,3.7405405,15,America/New_York,EDT,-14400000,0.62,,,26.83,16.36,18.89,21.83,35.58k,39.1k,16.39M,,10.06M,1.59%,57.81%,307.03k,7.73,,1.87%,302.83k,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-32.41%,-29.86%,-9.60%,-21.04%,44.63M,3.09,43.00%,28.71M,-12.31M,-14.46M,-1.11,,78.87M,5.11,7.02M,8.18,5.63,5.55,-12.21M,-9.82M,Value,3079883,Healthcare,257,"Itamar Medical Ltd., a medical technology company, develops and commercializes non-invasive medical devices and solutions for the treatment of respiratory sleep disorders. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enable to conduct home sleep apnea tests for the treatment of sleep apnea, such as obstructive sleep apnea; EndoPAT device that diagnoses endothelial dysfunction; and Loop device, a wrist device for measuring and recording physiological parameters, such as SpO2, respiration rate, and heart rate. The company operates in the United States, Canada, Europe, Israel, Japan, rest of the Asia Pacific, and internationally. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was incorporated in 1997 and is headquartered in Caesarea, Israel.",Caesarea,972 4 617 7000,1609372800,Israel,http://www.itamar-medical.com,86400,9 Halamish Street,972 4 627 5598,Medical Devices,North Industrial Zone PO Box 3579
